Article Versions Notes

Bychkova AV, Yakunina MN, Lopukhova MV, Degtyarev YN, Motyakin MV, Pokrovsky VS, Kovarski AL, Gorobets MG, Retivov VM, Khachatryan DS. Albumin-Functionalized Iron Oxide Nanoparticles for Theranostics: Engineering and Long-Term In Situ Imaging. Pharmaceutics. 2022; 14(12):2771. https://doi.org/10.3390/pharmaceutics14122771

Bychkova, Anna V., Marina N. Yakunina, Mariia V. Lopukhova, Yevgeniy N. Degtyarev, Mikhail V. Motyakin, Vadim S. Pokrovsky, Alexander L. Kovarski, Maria G. Gorobets, Vasily M. Retivov, and Derenik S. Khachatryan. 2022. "Albumin-Functionalized Iron Oxide Nanoparticles for Theranostics: Engineering and Long-Term In Situ Imaging" Pharmaceutics 14, no. 12: 2771. https://doi.org/10.3390/pharmaceutics14122771

Bychkova, A. V., Yakunina, M. N., Lopukhova, M. V., Degtyarev, Y. N., Motyakin, M. V., Pokrovsky, V. S., Kovarski, A. L., Gorobets, M. G., Retivov, V. M., & Khachatryan, D. S. (2022). Albumin-Functionalized Iron Oxide Nanoparticles for Theranostics: Engineering and Long-Term In Situ Imaging. Pharmaceutics, 14(12), 2771. https://doi.org/10.3390/pharmaceutics14122771